دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Opioid Use Disorder, Cannabis Use Disorder, and a Mindfulness Intervention Affecting Pain-Related Neural Substrates
Ned H. Kalin, M.D.
doi : 10.1176/appi.ajp.20220713
Volume 179, Issue 10
Understanding the Risks of Long-Term Opioid Therapy for Chronic Pain
Mark D. Sullivan, M.D., Ph.D., and Jane C. Ballantyne, M.D.
Flexible Buprenorphine/Naloxone Treatment Models: Safe and Effective in Reducing Opioid Use Among Persons With Prescription Opioid Use Disorder
Elizabeth C. Saunders, Ph.D.
Understanding Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration in the Era of Legalization
Stephanie Lake, Ph.D., and Ziva D. Cooper, Ph.D.
Can You Feel the Burn? Using Neuroimaging to Illuminate the Mechanisms of Mindfulness Interventions for Pain
Amy Gillespie, Ph.D., and Catherine J. Harmer, D.Phil.
Opioid Use Disorder: Pernicious and Persistent
Cecilia L. Bergeria, Ph.D., and Eric C. Strain, M.D.
Diagnosing Prescription Opioid Use Disorder in Patients Using Prescribed Opioids for Chronic Pain
Deborah S. Hasin, Ph.D., Dvora Shmulewitz, Ph.D., Malka Stohl, M.S., Eliana Greenstein, M.A., M.P.H., Efrat Aharonovich, Ph.D., Kenneth R. Petronis, M.P.H., Ph.D., Michael Von Korff, Ph.D., Samyadev Datta, M.D., Nomita Sonty, Ph.D., Stephen Ross, M.D., Charles Inturrisi, Ph.D., Michael L. Weinberger, M.D., Jennifer Scodes, M.S., Melanie M. Wall, Ph.D.
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial
Didier Jutras-Aswad, M.D., M.Sc., Bernard Le Foll, M.D., Ph.D., Keith Ahamad, M.D., Ron Lim, M.D., Julie Bruneau, M.D., M.Sc., Benedikt Fischer, Ph.D., Jürgen Rehm, Ph.D., T. Cameron Wild, Ph.D., Evan Wood, M.D., Ph.D., Suzanne Brissette, M.D., M.Sc., Lea Gagnon, Ph.D., Jill Fikowski, M.P.H., Omar Ledjiar, M.Sc., Benoit Masse, Ph.D., M. Eugenia Socias, M.D., M.Sc., for the OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse
Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder
Lewei (Allison) Lin, M.D., M.S., Lan Zhang, Ph.D., Hyungjin Myra Kim, Sc.D., Madeline C. Frost, M.P.H.
Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005–2019
Deborah S. Hasin, Ph.D., Andrew J. Saxon, M.D., Carol Malte, M.S.W., Mark Olfson, M.D., M.P.H., Katherine M. Keyes, Ph.D., Jaimie L. Gradus, D.M.Sc., D.Sc., Magdalena Cerdá, Sc.D., Charles C. Maynard, Ph.D., Salomeh Keyhani, M.D., Silvia S. Martins, M.D., Ph.D., David S. Fink, Ph.D., Ofir Livne, M.D., Zachary Mannes, Ph.D., Melanie M. Wall, Ph.D.
Neural Signatures of Pain Modulation in Short-Term and Long-Term Mindfulness Training: A Randomized Active-Control Trial
Joseph Wielgosz, Ph.D., Tammi R.A. Kral, Ph.D., David M. Perlman, Ph.D., Jeanette A. Mumford, Ph.D., Tor D. Wager, Ph.D., Antoine Lutz, Ph.D., Richard J. Davidson, Ph.D.
